Quality of life and antihypertensive effect with nebivolol and losartan

American Journal of Hypertension

Volumn 18, Issue 8, 2005, Pages 1060-1066

  Van Bortel, Luc M ^a   Bulpitt, Christopher J ^b   Fici, Francesco ^c  

^a GHENT UNIVERSITY   (Belgium)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Angiotensin receptor blockers; Losartan; Nebivolol; Quality of life; adrenergic blocking agents

Indexed keywords

HYDROCHLOROTHIAZIDE; LOSARTAN; NEBIVOLOL; PLACEBO;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE THERAPY; ARTHRALGIA; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; ERECTILE DYSFUNCTION; FAINTNESS; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MYALGIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 23744511758     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.03.733     Document Type: Editorial

References (29)

1. A.D. Bremner Antihypertensive medication and quality of life - silent treatment of a silent killer? Cardiovasc Drugs Ther 16 2002 353 364
2. K. Burstrom, M. Johannesson, F. Diderichsen Health-related quality of life by disease and socio-economic group in the general population in Sweden Health Policy 55 2001 51 69
3. F.J. Mena-Martin, J.C. Martin-Escudero, F. Simal-Blanco, J.L. Carretero-Ares, D. Arzua-Mouronte, V. Herreros-Fernandez Health-related quality of life of subjects with known and unknown hypertension results from the population-based Hortega study J Hypertens 21 2003 1283 1289
4. B. Chamontin, L. Poggi, T. Lang, J. Menard, H. Chevalier, H. Gallois, O. Cremier Prevalence, treatment, and control of hypertension in the French population Data from a survey on high blood pressure in general practice, 1994 Am J Hypertens 11 1998 759 762
5. L. Hansson "Why don't you do as I tell you?" Compliance and antihypertensive regimes Int J Clin Pract 56 2002 191 196
6. G. Mancia, E.A. Rosei, R. Cifkova, G. DeBacker, S. Erdine, R. Fagard, C. Farsang, A.M. Heagerty, K. Kawecka-Jaszcs, W. Kiowski, S. Kjeldsen, T. Luscher, G. McInnes, J.M. Mallion, E.O. Brien, N.R. Poulter, S.G. Priori, K.H. Rahn, J.L. Rodicio, L.M. Ruilope, M. Safar, J.A. Staessen, P. van Zwieten, B. Waeber, B. Williams, A. Zanchetti, F. Zannad 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension J Hypertens 21 2003 1011 1053
7. P. Hjemdahl, I.K. Wiklund Quality of life on antihypertensive drug therapy scientific endpoint or marketing exercise? J Hypertens 10 1992 1437 1446
8. S.H. Croog, S. Levine, M.A. Testa, B. Brown, C.J. Bulpitt, C.D. Jenkins, B.H. Williams The effects of antihypertensive therapy on the quality of life N Engl J Med 14 1986 1657 1664
9. L.M. Van Bortel, A.J. Ament Selective versus nonselective beta adrenoceptor antagonists in hypertension Pharmacoeconomics 8 1995 513 523
10. S.S. Steiner, A.J. Friedhoff, B.L. Wilson, J.R. Wecker, J.P. Santo Antihypertensive therapy and quality of life a comparison of atenolol, captopril, enalapril and propranolol J Hum Hypertens 4 1990 217 225
11. J.G. Breed, R. Ciampricotti, G.P. Tromp, F.A. Valster, E. Lageweg, L.M. Van Bortel Quality of life perception during antihypertensive treatment a comparitive study of bisoprolol and enalapril J Cardiovasc Pharmacol 20 1992 750 755
12. A.J. Palmer, A.E. Fletcher, P.J. Rudge, C.D. Andrews, T.S. Callaghan, C.J. Bulpitt Quality of life in hypertensives treated with atenolol or captopril a double-blind crossover trial J Hypertens 10 1992 1409 1416
13. J.N. de Hoon, F.H. Vanmolkot, L.L. van de Ven, L.M. Van Bortel Quality of life comparison between bisoprolol and nifedipine retard in hypertension Cardiovasc Drugs Ther 11 1997 465 471
14. S. Wassertheil-Smoller, M.D. Blaufox, A. Oberman, B.R. Davis, C. Swencionis, M.O. Knerr, C.M. Hawkins, H.G. Langford Effect of antihypertensives on sexual function and quality of life the TAIM study Ann Intern Med 114 1991 613 620
15. F.H. Vanmolkot, J.N. de Hoon, L.L. van de Ven, L.M. Van Bortel Impact of antihypertensive treatment on quality of life comparison between bisoprolol and bendrofluazide J Hum Hypertens 13 1999 559 563
16. B. Dahlof, L.H. Lindholm, S. Carney, P.J. Pentikainen, J. Ostergren LOA Study Group Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being J Hypertens 15 1997 1327 1335
17. T. Hedner, S. Oparil, K. Rasmussen, A. Rapelli, M. Gatlin, P. Kobi, J. Sullivan, P. Oddou-Stock A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension Am J Hypertens 12 1999 414 417
18. J. Wogen, C.A. Kreilick, R.C. Livornese, F. Frech A population-based study of compliance and persistency with cardiovascular agents used in hypertension management Am J Hypertens 14 2001 112A
19. L.M. Van Bortel, J.N. de Hoon, M.J. Kool, J.A. Wijnen, C.I. Vertommen, L.G. Van Nueten Pharmacological properties of nebivolol in man Eur J Clin Pharmacol 51 1997 379 384
20. N. Tzemos, P.O. Lim, T.M. MacDonald Nebivolol reverses endothelial dysfunction in essential hypertension. A randomised, double-blind, crossover study Circulation 104 2001 511 514
21. M. Dawes, S.E. Brett, P.J. Chowienczyk, T.G. Mant, J.M. Ritter The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension Br J Clin Pharmacol 48 1999 460 463
22. L.M. Van Bortel, J.G. Breed, J. Joosten, J.A. Kragten, F.A. Lustermans, J.M. Mooij Nebivolol in hypertension a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life J Cardiovasc Pharmacol 21 1993 856 862
23. C.J. Bulpitt, A.E. Fletcher The measurement of quality of life in hypertensive patients a practical approach Br J Clin Pharmacol 30 1990 353 364
24. M.A. Testa, R.B. Anderson, J.F. Nackley, N.K. Hollenberg Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril N Engl J Med 328 1993 907 913
25. A.E. Fletcher, C.J. Bulpitt, D.M. Chase, W.C.J. Collins, C.D. Furberg, T.K. Goggin, A.J. Hewett, A.M. Neiss Quality of life with three antihypertensive treatments cilazapril, atenolol, nifedipine Hypertension 19 1992 499 507
26. R. Fogari, A. Zoppi, L. Poletti, G. Marasi, A. Mugellini, L. Corradi Sexual activity in hypertensive men treated with valsartan or carvedilol a crossover study Am J Hypertens 14 2001 27 31
27. P.L. De Pablos-Velasco, F. Pazos Toral, J.E. Esmatjes, F. Fernandez-Vega, M.L. Lopez de la Torre, A. Pozuelo, L.M. Ruilope Losartan titration versus diuretic combination in type 2 diabetic patients J Hypertens 20 2002 715 719
28. E.L. Idler, Y. Benyamini Self-related health and mortality a review of twenty-seven community studies J Health Soc Behav 38 1997 21 37
29. E.C. Rake, E. Breeze, A.E. Fletcher Quality of life and cough on antihypertensive treatment a randomised trial of eprosartan, enalapril and placebo J Hum Hypertens 15 2001 863 867